| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |